ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
France's BioHub program, developed to encourage industrial biotechnology in the center of the country, is getting a boost from two recent developments.
Roquette, one of Europe's largest producers of starch and starch derivatives, has joined forces with chemical maker DSM to commercialize biobased succinic acid. The partners plan to open a demonstration plant in Lestrem, France, by the end of 2009.
Succinic acid, currently produced from crude oil or natural gas, is used in such industrial markets as pharmaceuticals, food, and automotive. It is also an intermediate for the production of several high-performance polymers—an area in which DSM is involved.
Biobased succinic acid will be produced by a fermentation process that the two companies developed. They say it is the first such production method in which carbon dioxide is actively used. The demonstration plant will have the capacity to produce several hundred metric tons per year. If the trial is successful, the partners will transfer the technology to large-scale production within two years.
Meanwhile, Clermont-Ferrand-based Metabolic Explorer has been granted a U.S. patent covering a fermentation method for producing 1,3-propanediol (PDO) from crude glycerin. The company already has European patents on the process.
"This is the first U.S. patent specifically related to converting glycerin into PDO at high yield using a coenzyme B12-independent metabolic pathway," says Philippe Soucaille, MetEx's chief scientific officer. The firm says it has developed "cell factories" for five chemical intermediates that together have annual sales of some $11 billion.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter